TickerFacts.

Kestra Medical Technologies, Ltd. (KMTS): Cash & Equivalents

Annual figures by period end, from SEC filings.

$99.71M
As of 2026-04-30
$68.56M
As of 2026-07-31
$237.59M2024-04-30: $8.25M2025-04-30: $237.59M2026-04-30: $99.71M$99.71M
2024-04-30 Cash & Equivalents (USD) 2026-04-30
Period endedCash & EquivalentsChange YoYSource filing
2026-04-30$99.71M-58.0%2026-07-14, Balance as of period end
2025-04-30$237.59Mn/m2026-07-14, Balance as of period end
2024-04-30$8.25Mn/a2025-07-17, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$99.71M-58.0%
NeuroPace Inc (NPCE)2025-12-31$21.69M+61.5%
Pulmonx Corp (LUNG)2025-12-31$69.75M-1.6%
Beta Bionics, Inc. (BBNX)2025-12-31$31.58M+3.8%
Delcath Systems, Inc. (DCTH)2025-12-31$43.45M+34.1%
Iradimed Corp (IRMD)2025-12-31$51.16M-2.1%
TELA Bio, Inc. (TELA)2025-12-31$50.84M-3.5%
Anika Therapeutics, Inc. (ANIK)2025-12-31$57.48M+3.3%
Orasure Technologies Inc (OSUR)2025-12-31$199.28M-25.6%

Compare KMTS, NPCE, LUNG, BBNX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗